FDA advisers back Pfizer shot for ages 5-11, paving way for Israel to follow
(Worthy News) – A panel of United States health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the US closer to beginning vaccinations in children ages 5 to 11.
A US Food and Drug Administration advisory panel voted unanimously with one abstention that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that’s been very rare in teens and young adults who get a much higher dose.
The FDA isn’t bound by the panel’s recommendation and is expected to make its own decision within days, though it is widely expected to okay the move. [ Source: Times of Israel (Read More…) ]
FDA Approves Pfizer Vaccine
The FDA committee has approved the Pfizer vaccine under the Emergency Use Authorization for kids aged 5-11, although it conceded it doesn’t know the long-term effects of the vaccination.
A voting member stated, “We’re never gonna learn about how safe the vaccine is until we start giving it.”
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌